Name: Lyka Labs Ltd. Financial Filings and Reports
Creator: FinancialReports
License: https://financialreports.eu/terms/

Filings indexed 1,205 across all filing types

Latest filing 2021-07-30 Regulatory Filings

Country IN India

Listing BSE.NS LYKALABS

About Lyka Labs Ltd.

https://www.lykalabs.com

Lyka Labs Ltd. specializes in the development, manufacture, and marketing of pharmaceutical formulations and active pharmaceutical ingredients (APIs). The company maintains a diverse product portfolio spanning multiple therapeutic categories, including anti-infectives, dermatologicals, cardiovascular agents, and pain management. A significant area of expertise for the organization is lyophilization technology, enabling the production of high-quality injectable formulations. The company operates advanced manufacturing facilities designed to meet international quality standards, supporting its operations in both domestic and global markets. Its core activities encompass the production of various dosage forms such as tablets, capsules, ointments, and sterile injectables, with a particular focus on specialized segments like cephalosporins and critical care medications.

Recent filings

Filing	Released	Lang
Shareholders meeting Regulatory Filings	2021-07-30	English
The Company convened its 42nd Annual General Meeting on 30th July, 2021 and the business mentioned in the Notice was transacted and passed with requisite majority. In this regard, .... Regulatory Filings	2021-07-30	English
We would like to inform you that the tenure of Shri. Atit N. Shukla (DIN: 07238247) as an Independent Director of the Company has come to an end in the 42nd Annual General Meeting of the .... Regulatory Filings	2021-07-30	English
Cessation Regulatory Filings	2021-07-30	English
Shareholders meeting Regulatory Filings	2021-07-30	English
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosures Requirements), 2015 we enclose herewith Summary Proceedings of the 42nd AGM of Lyka Labs Limited held today through .... Regulatory Filings	2021-07-30	English

Browse filings by year

17 years

	ID	Filing	Released	Lang
2021 15 filings
	43209423	Shareholders meeting Regulatory Filings	2021-07-30	English
	45350787	The Company convened its 42nd Annual General Meeting on 30th July, 2021 and the business mentioned in the Notice was transacted and passed with requisite majority. In this regard, .... Regulatory Filings	2021-07-30	English
	45350788	We would like to inform you that the tenure of Shri. Atit N. Shukla (DIN: 07238247) as an Independent Director of the Company has come to an end in the 42nd Annual General Meeting of the .... Regulatory Filings	2021-07-30	English
	43210817	Cessation Regulatory Filings	2021-07-30	English
	43210971	Shareholders meeting Regulatory Filings	2021-07-30	English
	45350790	Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosures Requirements), 2015 we enclose herewith Summary Proceedings of the 42nd AGM of Lyka Labs Limited held today through .... Regulatory Filings	2021-07-30	English
	45350791	The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 30, 2021 for Nehal Narendra Gandhi Regulatory Filings	2021-07-30	English
	44019274	Board Meeting — Financial Results Regulatory Filings	2021-07-28	English
	45350792	LYKA LABS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/08/2021 ,inter alia, to consider and approve This is to inform you that the meeting .... Regulatory Filings	2021-07-28	English
	43184600	Disclosure under SEBI Takeover Regulations Major Shareholding Notification	2021-07-27	English
	45350793	The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 27, 2021 for Narendra I Gandhi Regulatory Filings	2021-07-27	English
	45350794	The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 27, 2021 for Nehal Narendra Gandhi Regulatory Filings	2021-07-27	English
	45350795	The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 20, 2021 for Narendra Ishwarlal Gandhi HUF Regulatory Filings	2021-07-20	English
	45350796	In Compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulation, 2018 please find enclosed Certificate for the quarter ended 30 June, 2021 received form M/s Link .... Regulatory Filings	2021-07-13	English
	43176591	Updates Regulatory Filings	2021-07-13	English

Page 53 of 81

Prev … 51 52 53 54 55 … Next

Market data

Market data not available

Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products

2,202 peers

Company	Ticker	Country	Sector
13260917 Canada Inc. Biotech developing oral small molecules to restore muscle s…	MSCL	CA	Manufacturing
1608557 Ontario Inc. Biopharmaceutical company dedicated to R&D, discovery, and …	OTROQ	CA	Manufacturing
3B BlackBio Dx Limited Develops molecular diagnostic kits for oncology, infectious…	3BBLACKBIO	IN	Manufacturing
3D Medicines Inc. Commercial-stage biopharma specializing in next-generation …	1244	HK	Manufacturing
3SBio Inc. Biopharmaceutical enterprise specializing in R&D, productio…	1530	KY	Manufacturing
4BASEBIO PLC Manufactures GMP-grade synthetic DNA for next-generation th…	4BB	GB	Manufacturing
4D Molecular Therapeutics, Inc. Develops genetic medicines using AAV vectors for ophthalmol…	FDMT	US	Manufacturing
4Front Ventures Corp. Vertically integrated cannabis operator managing cultivatio…	FFNT	CA	Manufacturing
4SC AG Biopharmaceutical company with no products under developmen…	VSC	DE	Manufacturing
60 DEGREES PHARMACEUTICALS, INC. Develops and commercializes medicines for infectious diseas…	SXTP	US	Manufacturing

Page 1 of 221

1 2 3 … Next

Lyka Labs Ltd. via the API

Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.

Get API access Read API reference

Base URLapi.financialreports.eu

Auth headerx-api-key

Company ID62602

TickerLYKALABS

ISININE933A01014

Endpoints

most-used routes for this company

GET	/api/companies/62602/	Company identity, sector, listing, identifiers
GET	/api/filings/?company=62602	Paginated list of all filings (filterable by type, date, language)
GET	/api/filings/{id}/	Single filing — metadata, document URL, processing status
GET	/api/filings/{id}/markdown/	Filing content as Markdown (PDF → text/tables/figures)
GET	/api/isins/?company=62602	All ISINs registered to this company
GET	/api/filing-types/	Reference: every filing-type code + category

Full reference: API reference · OpenAPI schema

cURL

latest filings for Lyka Labs Ltd.

$ curl https://api.financialreports.eu/api/filings/?company=62602 \
    -H "x-api-key: $FR_API_KEY" \
    -H "Accept: application/json"

Python

requests

import requests

r = requests.get(
    "https://api.financialreports.eu/api/filings/",
    params={"company": 62602},
    headers={"x-api-key": API_KEY},
)
filings = r.json()["results"]

MCP server

Claude · Claude Code · ChatGPT

Claude setup ChatGPT setup Claude Code setup

// MCP server URL
https://mcp.financialfilings.com/mcp

// Once connected, the LLM can query this company directly:
"Pull the latest 5 filings for Lyka Labs Ltd. (id: 62602)"

Lyka Labs Ltd. — Investor Relations & Filings